Clin2
NCT03338387Possibly a fitEnrolling by invitation

Test effects of gut hormones in bulimia

Eating DisorderBulimia Nervosa

Part of Mental health clinical trials.

This trial studies how growth-related and gut hormones affect ghrelin, a hunger-related hormone, in people with bulimia. It may help researchers understand the body changes behind bulimia and how hormones and appetite signals work.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
24 people
Ages
18 years to 30 years
Study type
Interventional

Who can take part

  • You have a diagnosis of bulimia nervosa
  • Your body mass index (BMI) is between 18 and 23
  • You do not have a history of heart disease
  • You do not have a history of bleeding disorders
  • You do not have diabetes, thyroid problems, or liver/stomach/intestine diseases
  • You are not pregnant, trying to become pregnant, or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05862389Recruiting
Study of how eating disorders work in the brain

This trial studies the underlying brain and behavior mechanisms of anorexia nervosa or bulimia nervosa. It may help researchers understand what drives these conditions and what could be targeted in future treatments.

Beijing
NCT05995496Recruiting
Brain changes after eating in women with bulimia

This study looks at how the brain's control over eating changes after a meal, especially in women with bulimia nervosa. You will have an MRI scan and eat a standard meal as part of the research.

New York, New York
NCT05614024Recruiting
Neurofeedback training during meals for bulimia

This trial tests whether “neurofeedback” training during eating can help reduce symptoms of bulimia nervosa. You would do meal-based sessions while receiving feedback meant to support your brain’s self-regulation during eating.

New York, New York
NCT07542145Recruiting· Phase 1
MDMA-Assisted Therapy for Bulimia Nervosa

This study tests whether MDMA (a drug that enhances emotional processing) combined with therapy can help people with bulimia nervosa who haven't improved with previous eating disorder treatment. Researchers will measure whether this approach reduces binge eating and purging behaviors.

New York, New York
NCT07581158Not yet recruiting
Improving self-control in bulimia nervosa

This study looks at how people with bulimia nervosa (an eating disorder marked by binge eating and purging) control their impulses, and tests a possible new way to help. It involves drinking a shake and completing tasks, which may help improve self-control and reduce binge-purge cycles.

New York, New York
NCT05353504Recruiting
Testing how gut changes affect food choices

This study looks at whether interventions that change your gut bacteria can change how you decide what to eat. It may help researchers understand the gut–brain link behind eating behavior.

Leipzig

Hear when a new Bulimia Nervosa trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.